MedPath

CONNECTA THERAPEUTICS S.L.

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

Neural Biomarkers in Fragile X Syndrome

Completed
Conditions
Neurotypical Adults
Fragile X Syndrome (FXS)
First Posted Date
2025-05-04
Last Posted Date
2025-05-04
Lead Sponsor
Connecta Therapeutics, S.L.
Target Recruit Count
20
Registration Number
NCT06957054
Locations
🇪🇸

Consorci Corporació Sanitaria Parc Taulí. Institut Investigació i Innovació Parc Taulí (I3PT), Sabadell, Barcelona, Spain

🇪🇸

Hospital del Mar Research Institute (HMRI), Barcelona, Spain

CTH120 First-in-Human Study: Single and Multiple Ascending Doses and Potential Food Interaction

Phase 1
Completed
Conditions
Fragile X Syndrome
Interventions
Other: Placebo
First Posted Date
2024-07-01
Last Posted Date
2025-01-23
Lead Sponsor
Connecta Therapeutics, S.L.
Target Recruit Count
76
Registration Number
NCT06480968
Locations
🇪🇸

Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.